Follow
Barry S. Taylor
Barry S. Taylor
Loxo Oncology, Eli Lilly
Verified email at loxooncology.com - Homepage
Title
Cited by
Cited by
Year
Comprehensive molecular portraits of human breast tumours
CGAR Network
Nature 490 (7418), 61-70, 2012
8948*2012
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
R McLendon, A Friedman, D Bigner, EG Van Meir, DJ Brat, ...
Nature 455 (7216), 1061-1068, 2008
63292008
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
59212012
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
56822011
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ...
Nature genetics 45 (10), 1113-1120, 2013
49612013
Integrative genomic profiling of human prostate cancer
BS Taylor, N Schultz, H Hieronymus, A Gopalan, Y Xiao, BS Carver, ...
Cancer cell 18 (1), 11-22, 2010
35562010
Integrated genomic characterization of endometrial carcinoma
DA Levine
Nature 497 (7447), 67-73, 2013
34742013
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
30712012
Comprehensive molecular profiling of lung adenocarcinoma
NAE Never-smoker
Nature 511, 543-50, 2014
29032014
Comprehensive molecular characterization of clear cell renal cell carcinoma
Cancer Genome Atlas Research Network
Nature 499 (7456), 43, 2013
22582013
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ...
Nature medicine 23 (6), 703-713, 2017
20532017
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
14492018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
14012018
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
BE Johnson, T Mazor, C Hong, M Barnes, K Aihara, CY McLean, ...
Science 343 (6167), 189-193, 2014
11832014
OncoKB: a precision oncology knowledge base
D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ...
JCO precision oncology 1, 1-16, 2017
11112017
Molecular determinants of response to anti–programmed cell death (PD)-1 and anti–programmed death-ligand 1 (PD-L1) blockade in patients with non–small-cell lung cancer profiled …
H Rizvi, F Sanchez-Vega, K La, W Chatila, P Jonsson, D Halpenny, ...
Journal of Clinical Oncology 36 (7), 633, 2018
8692018
DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
R Rosenthal, N McGranahan, J Herrero, BS Taylor, C Swanton
Genome biology 17 (1), 1-11, 2016
7402016
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
I Landa, T Ibrahimpasic, L Boucai, R Sinha, JA Knauf, RH Shah, S Dogan, ...
The Journal of clinical investigation 126 (3), 1052-1066, 2016
7042016
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
J Barretina, BS Taylor, S Banerji, AH Ramos, M Lagos-Quintana, ...
Nature genetics 42 (8), 715-721, 2010
6962010
Genome sequencing identifies a basis for everolimus sensitivity
G Iyer, AJ Hanrahan, MI Milowsky, H Al-Ahmadie, SN Scott, ...
Science 338 (6104), 221, 2012
6732012
The system can't perform the operation now. Try again later.
Articles 1–20